It is a chemicals private limited company based in Bhubaneswar, Orissa, India, established in 2010.
2010 | Bhubaneswar, Orissa, India | Struck OffSedil India Pharmaceuticals Private Limited, a struck off private limited company, was established on 09 August 2010 in Bhubaneswar, Orissa, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24230OR2010PTC012322. Registered under ROC Roc Cuttack. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.
Its leadership includes Dilip Kumar Padhi (Director), Dillip Kumar Rout (Director), Bibekananda Nayak (Director). Its latest AGM occurred on 30 October 2011, with the balance sheet filed on 31 March 2011. It is based at Plot No-1164,Hanspal Nahar Kanta, Bhubaneswar, Orissa, 752101.
U24230OR2010PTC012322
012322
09 August 2010
₹1.00 M
₹0.50 M
Roc Cuttack
Unlisted
Struck Off
Explore comprehensive insights into Sedil India Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dilip Kumar Padhi | Director | 09 Aug 2010 | Current |
| Dillip Kumar Rout | Director | 09 Aug 2010 | Current |
| Bibekananda Nayak | Director | 09 Aug 2010 | Current |
| Pradip Kumar Nayak | Managing Director | 09 Aug 2010 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Sedil India Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Sedil India Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sedil India Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sedil India Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sedil India Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sedil India Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Oct 2011 as per latest MCA records. was completed.
Progress on Sedil India Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2011 with Roc Cuttack. was documented.
Progress on Dilip Kumar Padhi was appointed as a Director was appointed as a Director on 09 Aug 2010 & has been associated with this company since 15 years 3 months . was documented.
The activity Dillip Kumar Rout was appointed as a Director was appointed as a Director on 09 Aug 2010 & has been associated with this company since 15 years 3 months . was completed.
The activity Bibekananda Nayak was appointed as a Director was appointed as a Director on 09 Aug 2010 & has been associated with this company since 15 years 3 months . was completed.
The activity Pradip Kumar Nayak was appointed as a Managing Director was appointed as a Managing Director on 09 Aug 2010 & has been associated with this company since 15 years 3 months . was completed.
The CIN of Sedil India Pharmaceuticals Private Limited is U24230OR2010PTC012322.
Sedil India Pharmaceuticals Private Limited is headquartered at Plot No-1164,Hanspal Nahar Kanta, Bhubaneswar, Orissa, 752101.
Sedil India Pharmaceuticals Private Limited was incorporated on 09 August 2010.
The current directors of Sedil India Pharmaceuticals Private Limited are
The primary industry of Sedil India Pharmaceuticals Private Limited is Chemicals.
Sedil India Pharmaceuticals Private Limited is unlisted.
The authorized capital of Sedil India Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX